Esperion Therapeutics
ESPR
#6506
Rank
C$1.17 B
Marketcap
C$4.56
Share price
0.00%
Change (1 day)
33.17%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2026 (TTM): C-$0.03295

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is C-$0.02868. In 2025 the company made an earnings per share (EPS) of C-$0.19 an increase over its 2024 EPS that were of C-$0.33.

EPS history for Esperion Therapeutics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.03295-82.32%
2025C-$0.19-43.48%
2024C-$0.33-89.15%
2023C-$3.04-40.28%
2022C-$5.09-62.87%
2021C-$13.7180.38%
2020C-$7.6050.14%
2019C-$5.06-53.18%
2018C-$10.817.41%
2017C-$10.07110.81%
2016C-$4.7747.35%
2015C-$3.240.89%
2014C-$3.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.02-3,650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$67.36-235,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C-$7.44 25,850.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
C-$0.20 600.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C-$0.16 450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C-$0.13 350.00%๐Ÿ‡บ๐Ÿ‡ธ USA